Starpharma Holdings Limited (SPL) - Research

$1.320

SPL General Information +

ASX Code SPL
Website http://www.starpharma.com
GICS Sub-Industry Pharmaceuticals
Market Cap ($M) 490
Current Price $1.320
Day High $1.340
Day Low $1.315
Last Close $1.320
Price Movement - ( No change )
Prices as at 16:40, 14 Jun 2019
+Security prices are delayed by at least 20 minutes and are indicative only.

SPL Company Overview

Business Description

Starpharma Holdings Limited (SPL) is a biotechnology company that engages in the development of dendrimer products for pharmaceutical, life science and other applications. SPL's underlying technology is built around dendrimers, a type of synthetic nanoscale polymer that is highly regular in size and structure and well suited to pharmaceutical uses. SPL has three core development programs: VivaGel portfolio, drug delivery, and agrochemicals.

SPL Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2020 F 0.00 -1.10 0.00% 0.00 0.00 0.00% 0.0%
2019 F 0.00 -4.10 0.00% 0.00 0.00 0.00% 0.0%
2018 A -10.29 -2.80 0.00% 0.00 0.00 0.00% 0.0%

SPL Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2018 A 2019 F 2020 F 2018 A 2019 F 2020 F 2018 A 2019 F 2020 F
Mayne Pharma Group (MYX) $815M -0.5645 -0.2404 0.7615 17.9443 23.6239 13.4115 0.00% 0.00% 0.00%
Starpharma (SPL) $491M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

SPL Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 9.18 0.00
Market 0.89 17.00 1.51 1.64
Sector 0.99 29.80 3.28 2.07

SPL Directors

Name Position Start Date
Dr Jacinth (Jackie) Kincaid Fairley Chief Executive Officer, Executive Director 1 Jul 2006
Ms Zita Peach Non-Executive Director 1 Oct 2011
Mr Peter R Turvey Non-Executive Director 19 Mar 2012
Mr Richard A Hazelton Non-Executive Director 1 Dec 2006
Mr Robert Bain Thomas Non-Executive Director, Non-Executive Chairman 4 Dec 2013

SPL Management

Name Position
Nigel Baade Chief Financial Officer,Company Secretary
A Eglezos Vice President, Business Development
J R Paull Vice President, Development & Regulatory Affairs
D J Owen Vice President, Research

SPL Substantial Shareholders

Holding Name
49,041,042 (13.36%) Allan Gray Australia Pty Ltd
37,069,789 (13.06%) M&G Investment Management Limited
25,549,892 (6.90%) FIL Limited

SPL Calendar of Events

Date Event
26 February 2020 Report (Interim)
20 August 2019 Report (Annual)
20 August 2019 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.